RECORD | Already taken place Tu, 12.10.2021
Join us at Virtual Biopharma Leadership Conclave 2021 and interact with industry's key opinion leaders, experts from Agilent on latest trends in Biopharma space.
Go to the webinar
Unsplash/Madison Agardi: Biopharma Leadership Conclave 2021 - Day1: Oligonucleotides, Gene Therapy, mRNA Vaccines
You will be updated on latest technological launches, analytical challenges & workflow solutions & latest applications through live talks, panel discussions from industries experts & Agilent Biopharma specialists.
Day 1: Oligonucleotides, Gene Therapy, mRNA Vaccines:
2.30 p.m. (IST) Setting the Stage
- Mr. Shailendra Chavan (Agilent Technologies)
2:40 p.m. (IST) mRNA Therapeutics: Journey from Concept to Clinical Reality
- Dr.Priyaranjan Pattanaik (Head, NBE Services, Aurigene Pharmaceutical Services)
3:10 p.m. (IST) Analytical Challenges And An Assessment Of Orthogonal Techniques In The Characterization Of Therapeutic Oligonucleotides
- Dr. Guru S Madugundu (Lead Scientist, Syngene International)
3:30 p.m. (IST) Oligonucleotides: Separation and Purification
- Ms. Paramjeet Khandpur (Agilent Technologies)
3:40 p.m. (IST) Rapid Analysis of mRNA 5’ Capping with High Resolution LC MS
- Dr. Brian Liau (Solution Development Scientist , Agilent Technologies, Singapore)
3:55 p.m. (IST) Considerations for ensuring Quality of Cell and Gene Therapy products
- Dr. Shashwati Basak (Biopharma Professional & Independent Consultant)
4:20 p.m. (IST) Analytical Tools for Characterizing Cell and Gene Therapy Products
- Dr. Smruti M. Phadnis (Biopharma Marketing Manager, Cell and Gene Therapy, Agilent Technologies United States)
4:40 p.m. (IST) onwards Panel Discussion
- Moderated by Dr. Vadi Bhat and Mr. Chirag Khambhati